Similar articles for PMID: 15736482

Year	Number of Results
1968	1
1987	2
1989	3
1990	5
1992	3
1993	1
1994	8
1995	8
1996	15
1997	14
1998	19
1999	17
2000	16
2001	17
2002	15
2003	10
2004	17
2005	24
2006	15
2007	11
2008	11
2009	7
2010	1
2011	4
2013	3
2014	1
2015	1
2016	1
2019	1
2022	0

1

Loss of heterozygosity at chromosomes 3p and 17p in primary non-small cell lung cancer.

Chmara M, Wozniak A, Ochman K, Kobierska G, Dziadziuszko R, Sosinska-Mielcarek K, Jassem E, Skokowski J, Jassem J, Limon J. Chmara M, et al. Anticancer Res. 2004 Nov-Dec;24(6):4259-63. Anticancer Res. 2004. PMID: 15736482 Free article.

2

3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.

Sanz-Ortega J, Saez MC, Sierra E, Torres A, Balibrea JL, Hernando F, Sanz-Esponera J, Merino MJ. Sanz-Ortega J, et al. J Pathol. 2001 Nov;195(4):429-34. doi: 10.1002/path.987. J Pathol. 2001. PMID: 11745674

3

Loss of heterozygosity at 3p in non-small cell lung cancer and its prognostic implication.

Mitsudomi T, Oyama T, Nishida K, Ogami A, Osaki T, Sugio K, Yasumoto K, Sugimachi K, Gazdar AF. Mitsudomi T, et al. Clin Cancer Res. 1996 Jul;2(7):1185-9. Clin Cancer Res. 1996. PMID: 9816286

4

Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers.

Grepmeier U, Dietmaier W, Merk J, Wild PJ, Obermann EC, Pfeifer M, Hofstaedter F, Hartmann A, Woenckhaus M. Grepmeier U, et al. Int J Oncol. 2005 Aug;27(2):481-8. Int J Oncol. 2005. PMID: 16010431

5

High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.

Wistuba II, Behrens C, Virmani AK, Mele G, Milchgrub S, Girard L, Fondon JW 3rd, Garner HR, McKay B, Latif F, Lerman MI, Lam S, Gazdar AF, Minna JD. Wistuba II, et al. Cancer Res. 2000 Apr 1;60(7):1949-60. Cancer Res. 2000. PMID: 10766185

6

Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.

Geradts J, Fong KM, Zimmerman PV, Maynard R, Minna JD. Geradts J, et al. Clin Cancer Res. 1999 Apr;5(4):791-800. Clin Cancer Res. 1999. PMID: 10213214 Clinical Trial.

7

[Prognostic value of heterozygosity loss in chromosome 3p in non-microcytic bronchogenic carcinoma].

Maestro ML, Izquierdo L, Sánchez-Pernaute A, Sanz Casla MT, González S, Torres A, del Barco V, Gómez A, Pérez Aguirre E, Balibrea JL. Maestro ML, et al. Med Clin (Barc). 1999 Apr 24;112(14):527-9. Med Clin (Barc). 1999. PMID: 10363238 Spanish.

8

Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.

Girard L, Zöchbauer-Müller S, Virmani AK, Gazdar AF, Minna JD. Girard L, et al. Cancer Res. 2000 Sep 1;60(17):4894-906. Cancer Res. 2000. PMID: 10987304

9

Loss of heterozygosity of chromosome 3p21 is associated with mutant TP53 and better patient survival in non-small-cell lung cancer.

Marsit CJ, Hasegawa M, Hirao T, Kim DH, Aldape K, Hinds PW, Wiencke JK, Nelson HH, Kelsey KT. Marsit CJ, et al. Cancer Res. 2004 Dec 1;64(23):8702-7. doi: 10.1158/0008-5472.CAN-04-2558. Cancer Res. 2004. PMID: 15574780

10

Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.

Manderson EN, Presneau N, Provencher D, Mes-Masson AM, Tonin PN. Manderson EN, et al. Mol Carcinog. 2002 Jun;34(2):78-90. doi: 10.1002/mc.10051. Mol Carcinog. 2002. PMID: 12112314

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed